Synthesis of the NK3 receptor antagonist AZD2624 in C-14-, H-3- and C-13-labeled forms
作者:Charles S. Elmore、Peter N. Dorff、Mark E. Powell、James E. Hall、Thomas R. Simpson
DOI:10.1002/jlcr.1858
日期:2011.5.15
treatment for schizophrenia, three labeled forms of the NK3 receptor antagonist AZD2624 have been prepared. [3H2]AZD2624 was synthesized by tritiodehalogenation for use in receptor occupancy and autoradiographic studies. [13C6]AZD2624 was prepared for use as an internal standard through the intermediacy of [13C6]isatin, and two C-14 isotopomers of AZD2624 were prepared from [14C]benzoic acid and [14C]isatin
为了支持开发精神分裂症抗精神病药物治疗的计划,已经制备了三种标记形式的 NK3 受体拮抗剂 AZD2624。[3H2]AZD2624 是通过三碘脱卤合成的,用于受体占用和放射自显影研究。[13C6]AZD2624 通过 [13C6] 靛红作为内标制备,AZD2624 的两种 C-14 同位素由 [14C] 苯甲酸和 [14C] 靛红制备,用于各种 DMPK 研究。版权所有 © 2011 John Wiley & Sons, Ltd.